Vasculitis affecting the kidney

Seminars in Diagnostic Pathology

Volumn 26, Issue 2, 2009, Pages 89-102

  John, Rohan ^a   Herzenberg, Andrew M ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

ANCA; Crescentic glomerulonephritis; Kidney; Vasculitis

Indexed keywords

MYELOBLASTIN; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ANAPHYLACTOID PURPURA; ANTIBODY TITER; AORTA ARCH SYNDROME; ARTICLE; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CRYOGLOBULINEMIA; DISEASE CLASSIFICATION; ELECTRON MICROSCOPY; GIANT CELL ARTERITIS; GLOMERULONEPHRITIS; HISTOPATHOLOGY; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNOFLUORESCENCE MICROSCOPY; KIDNEY BIOPSY; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEPHRITIS; NONHUMAN; PATHOGENESIS; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RENAL VASCULITIS; RISK ASSESSMENT; RISK FACTOR; SMALL VESSEL VASCULITIS; VASCULITIS;

ANIMALS; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; KIDNEY; KIDNEY DISEASES; VASCULITIS;

EID: 70349515151     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2009.08.001     Document Type: Article

References (136)

1. Rao J.K., Allen N.B., and Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 129 (1998) 345-352
2. Zeek P.M. Periarteritis nodosa; a critical review. Am J Clin Pathol 22 (1952) 777-790
3. Cohen B.A., and Clark W.F. Pauci-immune renal vasculitis: Natural history, prognostic factors, and impact of therapy. Am J Kidney Dis 36 (2000) 914-924
4. Lie J.T. Nomenclature and classification of vasculitis: Plus ca change, plus c'est la meme chose. Arthritis Rheum 37 (1994) 181-186
5. Hunder G.G., Arend W.P., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 33 (1990) 1065-1067
6. Jennette J.C., Falk R.J., Andrassy K., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 (1994) 187-192
7. Davies D.J. Small vessel vasculitis. Cardiovasc Pathol 14 (2005) 335-346
8. Booth A.D., Almond M.K., Burns A., et al. Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis 41 (2003) 776-784
9. Stilmant M.M., Bolton W.K., Sturgill B.C., et al. Crescentic glomerulonephritis without immune deposits: Clinicopathologic features. Kidney Int 15 (1979) 184-195
10. Kallenberg C.G. Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis. Clin Rheumatol 9 (1990) 132-135
11. Jennette J.C., Wilkman A.S., and Falk R.J. Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis. Am J Pathol 135 (1989) 921-930
12. Falk R.J., and Jennette J.C. ANCA small-vessel vasculitis. J Am Soc Nephrol 8 (1997) 314-322
13. Morgan M.D., Harper L., Williams J., et al. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 17 (2006) 1224-1234
14. Fauci A.S., Haynes B., and Katz P. The spectrum of vasculitis: Clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 89 (1978) 660-676
15. Carlson J.A., Ng B.T., and Chen K.R. Cutaneous vasculitis update: Diagnostic criteria, classification, epidedmiology, etiology, pathogenesis, evaluation and prognosis. Am J Dermatopathol 27 (2005) 504-528
16. Jennette J.C., and Falk R.J. Small-vessel vasculitis. N Engl J Med 337 (1997) 1512-1523
17. Fauci A.S., and Wolff S.M. Wegener's granulomatosis: Studies in eighteen patients and a review of the literature. Medicine (Baltimore) 52 (1973) 535-561
18. Davies D.J., Moran J.E., Niall J.F., et al. Segmental necrotising glomerulonephritis with antineutrophil antibody: Possible arbovirus aetiology?. Br Med J (Clin Res Ed) 285 (1982) 606
19. van der Woude F.J., Rasmussen N., Lobatto S., et al. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1 (1985) 425-429
20. Falk R.J., and Jennette J.C. Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318 (1988) 1651-1657
21. Jenne D.E., Tschopp J., Ludemann J., et al. Wegener's autoantigen decoded. Nature 346 (1990) 520
22. Savige J.A., Paspaliaris B., Silvestrini R., et al. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. J Clin Pathol 51 (1998) 568-575
23. Hagen E.C., Daha M.R., Hermans J., et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 53 (1998) 743-753
24. Savige J., Davies D., Falk R.J., et al. Antineutrophil cytoplasmic antibodies and associated diseases: A review of the clinical and laboratory features. Kidney Int 57 (2000) 846-862
25. Vizjak A., Nagode B., Rott T., et al. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases. Wien Klin Wochenschr 112 (2000) 665-670
26. Savige J., Gillis D., Benson E., et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 111 (1999) 507-513
27. Jennette J.C., and Falk R.J. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr Opin Rheumatol 20 (2008) 55-60
28. Falk R.J., and Jennette J.C. ANCA are pathogenic-Oh yes they are!. J Am Soc Nephrol 13 (2002) 1977-1979
29. Kallenberg C.G. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
30. Kallenberg C.G., Heeringa P., and Stegeman C.A. Mechanisms of disease: Pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheumatol 2 (2006) 661-670
31. Falk R.J., Terrell R.S., Charles L.A., et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 87 (1990) 4115-4119
32. Savage C.O., Pottinger B.E., Gaskin G., et al. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity toward cultured endothelial cells. Am J Pathol 141 (1992) 335-342
33. Rarok A.A., Limburg P.C., and Kallenberg C.G. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J Leukoc Biol 74 (2003) 3-15
34. Falk R.J., Hogan S., Carey T.S., et al. Clinical course of anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and systemic vasculitis. The Glomerular Disease Collaborative Network. Ann Intern Med 113 (1990) 656-663
35. Ralston D.R., Marsh C.B., Lowe M.P., et al. Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 100 (1997) 1416-1424
36. Weidner S., Neupert W., Goppelt-Struebe M., et al. Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum 44 (2001) 1698-1706
37. Sanders J.S., Huitma M.G., Kallenberg C.G., et al. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment. Rheumatology (Oxford) 45 (2006) 724-729
38. Boomsma M.M., Stegeman C.A., van der Leij M.J., et al. Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: A prospective study. Arthritis Rheum 43 (2000) 2025-2033
39. Schlieben D.J., Korbet S.M., Kimura R.E., et al. Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 45 (2005) 758-761
40. Harper J.M., Thiru S., Lockwood C.M., et al. Myeloperoxidase autoantibodies distinguish vasculitis mediated by anti-neutrophil cytoplasm antibodies from immune complex disease in MRL/Mp-lpr/lpr mice: A spontaneous model for human microscopic angiitis. Eur J Immunol 28 (1998) 2217-2226
41. Heeringa P., Brouwer E., Klok P.A., et al. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol 149 (1996) 1695-1706
42. Brouwer E., Huitema M.G., Klok P.A., et al. Antimyeloperoxidase-associated proliferative glomerulonephritis: An animal model. J Exp Med 177 (1993) 905-914
43. Little M.A., Smyth C.L., Yadav R., et al. Antineutrophil cytoplasm antibodies directed against myeloperoxidase augment leukocyte-microvascular interactions in vivo. Blood 106 (2005) 2050-2058
44. Xiao H., Heeringa P., Hu P., et al. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110 (2002) 955-963
45. Xiao H., Heeringa P., Liu Z., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 167 (2005) 39-45
46. Huugen D., Xiao H., van Esch A., et al. Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: Role of tumor necrosis factor-alpha. Am J Pathol 167 (2005) 47-58
47. Xiao H., Schreiber A., Heeringa P., et al. Alternative complement pathway in the pathogenesis of disease mediated by anti-neutrophil cytoplasmic autoantibodies. Am J Pathol 170 (2007) 52-64
48. Huugen D., van Esch A., Xiao H., et al. Inhibition of complement factor C5 protects against anti-myeloperoxidase antibody-mediated glomerulonephritis in mice. Kidney Int 71 (2007) 646-654
49. Cunningham M.A., Huang X.R., Dowling J.P., et al. Prominence of cell-mediated immunity effectors in "pauci-immune" glomerulonephritis. J Am Soc Nephrol 10 (1999) 499-506
50. Weidner S., Carl M., Riess R., et al. Histologic analysis of renal leukocyte infiltration in antineutrophil cytoplasmic antibody-associated vasculitis: Importance of monocyte and neutrophil infiltration in tissue damage. Arthritis Rheum 50 (2004) 3651-3657
51. de Lind van Wijngaarden R.A., van Rijn L., Hagen E.C., et al. Hypotheses on the etiology of antineutrophil cytoplasmic autoantibody associated vasculitis: The cause is hidden, but the result is known. Clin J Am Soc Nephrol 3 (2008) 237-252
52. Nowack R., Lehmann H., Flores-Suarez L.F., et al. Familial occurrence of systemic vasculitis and rapidly progressive glomerulonephritis. Am J Kidney Dis 34 (1999) 364-373
53. Morita S., Ueda Y., and Eguchi K. Anti-thyroid drug-induced ANCA-associated vasculitis: A case report and review of the literature. Endocr J 47 (2000) 467-470
54. Gao Y., Zhao M.H., Guo X.H., et al. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr Res 30 (2004) 205-213
55. Schreiber A., Luft F.C., and Kettritz R. Membrane proteinase 3 expression and ANCA-induced neutrophil activation. Kidney Int 65 (2004) 2172-2183
56. Stegeman C.A., Tervaert J.W., Sluiter W.J., et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 120 (1994) 12-17
57. Pendergraft III W.F., Preston G.A., Shah R.R., et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med 10 (2004) 72-79
58. Bautz D.J., Preston G.A., Lionaki S., et al. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol 19 (2008) 2421-2429
59. Jennette J.C., and Thomas D.B. Crescentic glomerulonephritis. Nephrol Dial Transplant 16 suppl 6 (2001) 80-82
60. Saxena R., Bygren P., Arvastson B., et al. Circulating autoantibodies as serological markers in the differential diagnosis of pulmonary renal syndrome. J Intern Med 238 (1995) 143-152
61. Niles J.L., Bottinger E.P., Saurina G.R., et al. The syndrome of lung hemorrhage and nephritis is usually an ANCA-associated condition. Arch Intern Med 156 (1996) 440-445
62. Hauer H.A., Bajema I.M., de Heer E., et al. Distribution of renal lesions in idiopathic systemic vasculitis: A three-dimensional analysis of 87 glomeruli. Am J Kidney Dis 36 (2000) 257-265
63. Magil A.B. Histogenesis of glomerular crescents. Immunohistochemical demonstration of cytokeratin in crescent cells. Am J Pathol 120 (1985) 222-229
64. Boucher A., Droz D., Adafer E., et al. Relationship between the integrity of Bowman's capsule and the composition of cellular crescents in human crescentic glomerulonephritis. Lab Invest 56 (1987) 526-533
65. Hauer H.A., Bajema I.M., van Houwelingen H.C., et al. Renal histology in ANCA-associated vasculitis: Differences between diagnostic and serologic subgroups. Kidney Int 61 (2002) 80-89
66. Jennette J.C. Rapidly progressive crescentic glomerulonephritis. Kidney Int 63 (2003) 1164-1177
67. Savage C.O., Winearls C.G., Evans D.J., et al. Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 56 (1985) 467-483
68. Vizjak A., Rott T., Koselj-Kajtna M., et al. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Am J Kidney Dis 41 (2003) 539-549
69. Bonsib S.M., and Goeken J.A. Renal artery stenosis modifies glomerular injury in antineutrophil cytoplasmic antibody-associated disease. Am J Kidney Dis 20 (1992) 509-512
70. Bonsib S.M., Goeken J.A., Fandel T., et al. Necrotizing medullary lesions in patients with ANCA associated renal disease. Mod Pathol 7 (1994) 181-185
71. Bajema I.M., Hagen E.C., Ferrario F., et al. Renal granulomas in systemic vasculitis. EC/BCR Project for ANCA-Assay Standardization. Clin Nephrol 48 (1997) 16-21
72. Bajema I.M., Hagen E.C., van der Woude F.J., et al. Wegener's granulomatosis: A meta-analysis of 349 literary case reports. J Lab Clin Med 129 (1997) 17-22
73. Haas M., and Eustace J.A. Immune complex deposits in ANCA-associated crescentic glomerulonephritis: A study of 126 cases. Kidney Int 65 (2004) 2145-2152
74. Rutgers A., Slot M., van Paassen P., et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis 46 (2005) 253-262
75. Tse W.Y., Howie A.J., Adu D., et al. Association of vasculitic glomerulonephritis with membranous nephropathy: A report of 10 cases. Nephrol Dial Transplant 12 (1997) 1017-1027
76. Haas M., Jafri J., Bartosh S.M., et al. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 36 (2000) 709-718
77. Hellmark T., Niles J.L., Collins A.B., et al. Comparison of anti-GBM antibodies in sera with or without ANCA. J Am Soc Nephrol 8 (1997) 376-385
78. Sinico R.A., Di Toma L., Maggiore U., et al. Renal involvement in Churg-Strauss syndrome. Am J Kidney Dis 47 (2006) 770-779
79. Guillevin L., and Lhote F. Distinguishing polyarteritis nodosa from microscopic polyangiitis and implications for treatment. Curr Opin Rheumatol 7 (1995) 20-24
80. Woywodt A., Haubitz M., Haller H., et al. Wegener's granulomatosis. Lancet 367 (2006) 1362-1366
81. Woywodt A., and Matteson E.L. Wegener's granulomatosis-Probing the untold past of the man behind the eponym. Rheumatology (Oxford) 45 (2006) 1303-1306
82. Sable-Fourtassou R., Cohen P., Mahr A., et al. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med 143 (2005) 632-638
83. Sinico R.A., Di Toma L., Maggiore U., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 52 (2005) 2926-2935
84. Kallenberg C.G. Churg-Strauss syndrome: Just one disease entity?. Arthritis Rheum 52 (2005) 2589-2593
85. Trejo O., Ramos-Casals M., Garcia-Carrasco M., et al. Cryoglobulinemia: Study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 80 (2001) 252-262
86. Roccatello D., Fornasieri A., Giachino O., et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomerulonephritis. Am J Kidney Dis 49 (2007) 69-82
87. Karras A., Noel L.H., Droz D., et al. Renal involvement in monoclonal (type i) cryoglobulinemia: Two cases associated with IgG3 kappa cryoglobulin. Am J Kidney Dis 40 (2002) 1091-1096
88. Tarantino A., Campise M., Banfi G., et al. Long-term predictors of survival in essential mixed cryoglobulinemic glomerulonephritis. Kidney Int 47 (1995) 618-623
89. D'Amico G. Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis. Kidney Int 54 (1998) 650-671
90. Ferrario F., Castiglione A., Colasanti G., et al. The detection of monocytes in human glomerulonephritis. Kidney Int 28 (1985) 513-519
91. Beddhu S., Bastacky S., and Johnson J.P. The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine (Baltimore) 81 (2002) 398-409
92. Ogihara T., Saruta T., Saito I., et al. Finger print deposits of the kidney in pure monoclonal IgG kappa cryoglobulinemia. Clin Nephrol 12 (1979) 186-190
93. Davin J.C., Ten Berge I.J., and Weening J.J. What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis?. Kidney Int 59 (2001) 823-834
94. Shrestha S., Sumingan N., Tan J., et al. Henoch Schonlein purpura with nephritis in adults: Adverse prognostic indicators in a UK population. QJM 99 (2006) 253-265
95. Magro C.M., and Crowson A.N. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol 21 (1999) 234-240
96. Pillebout E., Thervet E., Hill G., et al. Henoch-Schonlein purpura in adults: Outcome and prognostic factors. J Am Soc Nephrol 13 (2002) 1271-1278
97. Descombes E., Droz D., Drouet L., et al. Renal vascular lesions in lupus nephritis. Medicine (Baltimore) 76 (1997) 355-368
98. Weening J.J., D'Agati V.D., Schwartz M.M., et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 15 (2004) 241-250
99. Appel G.B., Pirani C.L., and D'Agati V. Renal vascular complications of systemic lupus erythematosus. J Am Soc Nephrol 4 (1994) 1499-1515
100. Banfi G., Bertani T., Boeri V., et al. Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis. Gruppo Italiano per lo Studio della Nefrite Lupica (GISNEL). Am J Kidney Dis 18 (1991) 240-248
101. Grishman E., and Venkataseshan V.S. Vascular lesions in lupus nephritis. Mod Pathol 1 (1988) 235-241
102. Appel G.B., Silva F.G., Pirani C.L., et al. Renal involvement in systemic lupus erythematosus (SLE): A study of 56 patients emphasizing histologic classification. Medicine (Baltimore) 57 (1978) 371-410
103. Nasr S.H., D'Agati V.D., Park H.R., et al. Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3 (2008) 682-690
104. Lewis E.J., Schwartz M.M., and Korbet S.M. Severe lupus nephritis: Importance of re-evaluating the histologic classification and the approach to patient care. J Nephrol 14 (2001) 223-227
105. Markowitz G.S., and D'Agati V.D. The ISN/RPS 2003 classification of lupus nephritis: An assessment at 3 years. Kidney Int 71 (2007) 491-495
106. Helin H.J., Korpela M.M., Mustonen J.T., et al. Renal biopsy findings and clinicopathologic correlations in rheumatoid arthritis. Arthritis Rheum 38 (1995) 242-247
107. Boers M., Croonen A.M., Dijkmans B.A., et al. Renal findings in rheumatoid arthritis: Clinical aspects of 132 necropsies. Ann Rheum Dis 46 (1987) 658-663
108. Harper L., Cockwell P., Howie A.J., et al. Focal segmental necrotizing glomerulonephritis in rheumatoid arthritis. QJM 90 (1997) 125-132
109. Qarni M.U., and Kohan D.E. Pauci-immune necrotizing glomerulonephritis complicating rheumatoid arthritis. Clin Nephrol 54 (2000) 54-58
110. Stokes M.B., Foster K., Markowitz G.S., et al. Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis. Nephrol Dial Transplant 20 (2005) 1400-1406
111. Mustila A., Korpela M., Mustonen J., et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: A marker of severe disease with associated nephropathy. Arthritis Rheum 40 (1997) 710-717
112. Moreland L., DiBartolomeo A., and Brick J. Rheumatoid vasculitis with intrarenal aneurysm formation. J Rheumatol 15 (1988) 845-849
113. Skopouli F.N. Kidney injury in Sjogren's syndrome. Nephrol Dial Transplant 16 suppl 6 (2001) 63-64
114. Goules A., Masouridi S., Tzioufas A.G., et al. Clinically significant and biopsy-documented renal involvement in primary Sjogren syndrome. Medicine (Baltimore) 79 (2000) 241-249
115. Molina R., Provost T.T., and Alexander E.L. Two types of inflammatory vascular disease in Sjogren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS-A) and with hypocomplementemia. Arthritis Rheum 28 (1985) 1251-1258
116. Henegar C., Pagnoux C., Puechal X., et al. A paradigm of diagnostic criteria for polyarteritis nodosa: Analysis of a series of 949 patients with vasculitides. Arthritis Rheum 58 (2008) 1528-1538
117. Agard C., Mouthon L., Mahr A., et al. Microscopic polyangiitis and polyarteritis nodosa: How and when do they start?. Arthritis Rheum 49 (2003) 709-715
118. Guillevin L., Mahr A., Callard P., et al. Hepatitis B virus-associated polyarteritis nodosa: Clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84 (2005) 313-322
119. Lhote F., Cohen P., and Guillevin L. Polyarteritis nodosa, microscopic polyangiitis and Churg-Strauss syndrome. Lupus 7 (1998) 238-258
120. Trepo C., and Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: The case against autoimmune intervention in pathogenesis. J Autoimmun 16 (2001) 269-274
121. Newburger J.W., and Fulton D.R. Kawasaki disease. Curr Opin Pediatr 16 (2004) 508-514
122. Wang J.N., Chiou Y.Y., Chiu N.T., et al. Renal scarring sequelae in childhood Kawasaki disease. Pediatr Nephrol 22 (2007) 684-689
123. Falcini F., Calabri G.B., Simonini G., et al. Bilateral renal artery stenosis in Kawasaki disease: A report of two cases. Clin Exp Rheumatol 24 (2006) 719-721
124. Burns J.C., and Glode M.P. Kawasaki syndrome. Lancet 364 (2004) 533-544
125. Hall J.K. Giant-cell arteritis. Curr Opin Ophthalmol 19 (2008) 454-460
126. Chatelain D., Duhaut P., Loire R., et al. Small-vessel vasculitis surrounding an uninflamed temporal artery: A new diagnostic criterion for polymyalgia rheumatica?. Arthritis Rheum 58 (2008) 2565-2573
127. Weyand C.M., Ma-Krupa W., and Goronzy J.J. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 3 (2004) 46-53
128. Lambert M., Weber A., Boland B., et al. Large vessel vasculitis without temporal artery involvement: Isolated form of giant cell arteritis?. Clin Rheumatol 15 (1996) 174-180
129. Small P., and Brisson M.L. Wegener's granulomatosis presenting as temporal arteritis. Arthritis Rheum 34 (1991) 220-223
130. Bert R.J., Antonacci V.P., Berman L., et al. Polyarteritis nodosa presenting as temporal arteritis in a 9-year-old child. AJNR Am J Neuroradiol 20 (1999) 167-171
131. Vanderschueren S., Depoot I., Knockaert D.C., et al. Microscopic haematuria in giant cell arteritis. Clin Rheumatol 21 (2002) 373-377
132. Medvedev G., Al-Shamari A.E., Copland M.A., et al. Isolated renal giant cell arteritis. Am J Kidney Dis 40 (2002) 658-661
133. Lupi-Herrera E., Sanchez-Torres G., Marcushamer J., et al. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 93 (1977) 94-103
134. Hall S., Barr W., Lie J.T., et al. Takayasu's arteritis. A study of 32 North American patients. Medicine (Baltimore) 64 (1985) 89-99
135. Chugh K.S., Jain S., Sakhuja V., et al. Renovascular hypertension due to Takayasu's arteritis among Indian patients. Q J Med 85 (1992) 833-843
136. Yoshimura M., Kida H., Saito Y., et al. Peculiar glomerular lesions in Takayasu's arteritis. Clin Nephrol 24 (1985) 120-127